CTI LIFE SCIENCES FUND L.P.
CTI Life Sciences Fund L.P. is a Montreal-based company founded in 2006.
The firm makes venture capital investments mostly in innovative high-quality biotech companies at the pre-clinical and clinical development stages, in North America and Europe with a focus primarily in Canada.
CTI Life Sciences Fund manages $375 million of assets, realized 7 exits as of Q4 2021 and had 3 successful FDA approvals.
In 2022, CTI Life Sciences Fund L.P. gave its support to Domain Therapeutics and invested to support the next phase of growth of the company.